{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:12:13Z","timestamp":1775261533037,"version":"3.50.1"},"reference-count":43,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"6","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":327,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Anxiety disorders are the most prevalent comorbid diagnoses in patients with bipolar disorder (BD). A comorbid anxiety diagnosis can significantly impact the severity of bipolar symptoms, increase the risk of suicidality, and decrease psychosocial functioning and quality of life. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force published recommendations for treatment in 2012 suggesting that specific anticonvulsant mood stabilizers and second-generation antipsychotics are the medications of choice to treat these comorbidities. Serotonergic antidepressant medications are first-line medications for the treatment of most anxiety disorders; however, this can be problematic for a patient with BD. Antidepressant use in BD has been associated with a risk of manic switch as well as potential destabilization of mood. Mood stabilizer therapy should be established for patients with comorbid BD and an anxiety disorder before other medications are added to address the anxiety disorder. While benzodiazepine medications are recommended as third-line therapy in the CANMAT task force recommendations, their use should be avoided in patients with comorbid BD, posttraumatic stress disorder, and substance use disorders. The use of benzodiazepines should in general be avoided for all patients if possible, based upon current clinical research. Interpersonal, cognitive behavioral, and relaxation therapy are effective for the treatment of anxiety symptoms, especially emotional experiences, in patients who are euthymic.<\/jats:p>","DOI":"10.9740\/mhc.2018.11.256","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T14:09:22Z","timestamp":1541081362000},"page":"256-263","source":"Crossref","is-referenced-by-count":18,"title":["Treatment of anxiety disorders in patients with comorbid bipolar disorder"],"prefix":"10.9740","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-3845","authenticated-orcid":false,"given":"Carol A.","family":"Ott","sequence":"first","affiliation":[{"name":"(Corresponding author) Clinical Professor of Pharmacy Practice, Department of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, Indiana; Clinical Pharmacy Specialist, Outpatient Psychiatry, Prevention and Recovery Center for Early Psychosis, Mood Disorders Clinic, Midtown Community Mental Health, Eskenazi Health, Indianapolis, Indiana, caott@iupui.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","reference":[{"issue":"2","key":"2020060307285864400_i2168-9709-8-6-256-b01","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/da.20279","article-title":"The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders","volume":"25","author":"Lee","year":"2008","journal-title":"Depress Anxiety"},{"issue":"8","key":"2020060307285864400_i2168-9709-8-6-256-b02","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S2215-0366(15)00112-1","article-title":"Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis","volume":"2","author":"Pavlova","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"2020060307285864400_i2168-9709-8-6-256-b03","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/da.22248","article-title":"Co-occurrence of anxiety and bipolar disorders: clinical and therapeutic overview","volume":"31","author":"V\u00e1zquez","year":"2014","journal-title":"Depress Anxiety"},{"issue":"7","key":"2020060307285864400_i2168-9709-8-6-256-b04","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jpsychires.2012.03.024","article-title":"Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population","volume":"46","author":"Sala","year":"2012","journal-title":"J Psychiatr Res"},{"issue":"1","key":"2020060307285864400_i2168-9709-8-6-256-b05","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/104012371202400103","article-title":"The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders","volume":"24","author":"Schaffer","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"2020060307285864400_i2168-9709-8-6-256-b06","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.comppsych.2016.08.007","article-title":"Bipolar I disorder with comorbid PTSD: demographic and clinical correlates in a sample of hospitalized patients","volume":"72","author":"Reddy","year":"2017","journal-title":"Compr Psychiatry"},{"key":"2020060307285864400_i2168-9709-8-6-256-b07","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jad.2017.11.028","article-title":"Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression","volume":"227","author":"Lorenzo-Luaces","year":"2018","journal-title":"J Affect Disord"},{"issue":"1-3","key":"2020060307285864400_i2168-9709-8-6-256-b08","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jad.2011.12.001","article-title":"Comorbid anxiety in bipolar spectrum disorders: a neglected research and treatment issue?","volume":"137","author":"Provencher","year":"2012","journal-title":"J Affect Disord"},{"key":"2020060307285864400_i2168-9709-8-6-256-b09","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jad.2015.06.005","article-title":"The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"186","author":"Amerio","year":"2015","journal-title":"J Affect Disord"},{"key":"2020060307285864400_i2168-9709-8-6-256-b10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jad.2014.05.026","article-title":"Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review","volume":"166","author":"Amerio","year":"2014","journal-title":"J Affect Disord"},{"issue":"Suppl 1","key":"2020060307285864400_i2168-9709-8-6-256-b11","first-page":"8","article-title":"Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders","volume":"67","author":"Keck","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"2020060307285864400_i2168-9709-8-6-256-b12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.genhosppsych.2010.07.004","article-title":"Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder","volume":"32","author":"Uguz","year":"2010","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"2020060307285864400_i2168-9709-8-6-256-b13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/YIC.0b013e3283576881","article-title":"Quetiapine augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: is response to treatment predictable?","volume":"27","author":"Carey","year":"2012","journal-title":"Int Clin Psychopharmacol"},{"key":"2020060307285864400_i2168-9709-8-6-256-b14","doi-asserted-by":"crossref","unstructured":"Shoja Shafti S, Kaviani H. Aripiprazole versus quetiapine in treatment-resistant obsessive-compulsive disorder: a double-blind clinical trial. Ther Adv Psychopharmacol. 2015;5(1):32-7. DOI: 10.1177\/2045125314560739. PubMed PMID: 25653829.","DOI":"10.1177\/2045125314560739"},{"issue":"2","key":"2020060307285864400_i2168-9709-8-6-256-b15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1176\/appi.ajp.2013.13020225","article-title":"Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD","volume":"171","author":"Deckersbach","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"3","key":"2020060307285864400_i2168-9709-8-6-256-b16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jad.2010.10.040","article-title":"Psychotherapies for comorbid anxiety in bipolar spectrum disorders","volume":"133","author":"Provencher","year":"2011","journal-title":"J Affect Disord"},{"key":"2020060307285864400_i2168-9709-8-6-256-b17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cpr.2014.11.002","article-title":"Psychological therapy for anxiety in bipolar spectrum disorders: a systematic review","volume":"35","author":"Stratford","year":"2015","journal-title":"Clin Psychol Rev"},{"issue":"4","key":"2020060307285864400_i2168-9709-8-6-256-b18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.comppsych.2009.11.001","article-title":"Correlates and impact of obsessive-compulsive comorbidity in bipolar disorder","volume":"51","author":"Magalh\u00e3es","year":"2010","journal-title":"Compr Psychiatry"},{"key":"2020060307285864400_i2168-9709-8-6-256-b19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jad.2014.05.017","article-title":"Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder","volume":"166","author":"Kim","year":"2014","journal-title":"J Affect Disord"},{"issue":"2","key":"2020060307285864400_i2168-9709-8-6-256-b20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/15748847113089990060","article-title":"Non-antidepressant pharmacological treatment of obsessive compulsive disorder: a comprehensive review","volume":"10","author":"Abdel-Ahad","year":"2015","journal-title":"Curr Clin Pharmacol"},{"issue":"11","key":"2020060307285864400_i2168-9709-8-6-256-b21","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","article-title":"The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders","volume":"170","author":"Pacchiarotti","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"3","key":"2020060307285864400_i2168-9709-8-6-256-b22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/bdi.12612","article-title":"Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis","volume":"20","author":"Fornaro","year":"2018","journal-title":"Bipolar Disord"},{"key":"2020060307285864400_i2168-9709-8-6-256-b23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jpsychires.2015.04.014","article-title":"Predictors of switch from depression to mania in bipolar disorder","volume":"66-67","author":"Niitsu","year":"2015","journal-title":"J Psychiatr Res"},{"key":"2020060307285864400_i2168-9709-8-6-256-b24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.psychres.2016.04.071","article-title":"The number of past manic episodes is the best predictor of antidepressant-emergent manic switch in a cohort of bipolar depressed patients","volume":"240","author":"Gorwood","year":"2016","journal-title":"Psychiatry Res"},{"issue":"3","key":"2020060307285864400_i2168-9709-8-6-256-b25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1176\/appi.ajp.2016.15040558","article-title":"Switch rates during acute treatment for bipolar II depression with lithium, sertraline, or the two combined: a randomized double-blind comparison","volume":"174","author":"Altshuler","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"2","key":"2020060307285864400_i2168-9709-8-6-256-b26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1176\/appi.ajp.2008.08030322","article-title":"Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression","volume":"166","author":"Frye","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"5","key":"2020060307285864400_i2168-9709-8-6-256-b27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/acps.12728","article-title":"A re-examination of antidepressant treatment-emergent mania in bipolar disorders: evidence of gender differences","volume":"135","author":"Scott","year":"2017","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"2020060307285864400_i2168-9709-8-6-256-b28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/eb-2016-102412","article-title":"Prevalence, impact and treatment of generalised anxiety disorder in bipolar disorder: a systematic review and meta-analysis","volume":"19","author":"Preti","year":"2016","journal-title":"Evid Based Ment Health"},{"issue":"1-3","key":"2020060307285864400_i2168-9709-8-6-256-b29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jad.2007.05.020","article-title":"Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes","volume":"105","author":"Albert","year":"2008","journal-title":"J Affect Disord"},{"issue":"1","key":"2020060307285864400_i2168-9709-8-6-256-b30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4088\/JCP.09r05815gre","article-title":"Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review","volume":"72","author":"Rakofsky","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"2020060307285864400_i2168-9709-8-6-256-b31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4088\/JCP.v69n0413","article-title":"Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study","volume":"69","author":"Maina","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2020060307285864400_i2168-9709-8-6-256-b32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4088\/JCP.12m08297","article-title":"A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder","volume":"75","author":"Suppes","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"2020060307285864400_i2168-9709-8-6-256-b33","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.4088\/JCP.13m08847","article-title":"Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial","volume":"75","author":"Gao","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2020060307285864400_i2168-9709-8-6-256-b34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jad.2012.07.016","article-title":"Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient","volume":"145","author":"Sheehan","year":"2013","journal-title":"J Affect Disord"},{"key":"2020060307285864400_i2168-9709-8-6-256-b35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jad.2017.05.011","article-title":"Transdiagnostic treatment of bipolar disorder and comorbid anxiety using the Unified Protocol for Emotional Disorders: a pilot feasibility and acceptability trial","volume":"219","author":"Ellard","year":"2017","journal-title":"J Affect Disord"},{"key":"2020060307285864400_i2168-9709-8-6-256-b36","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"1","key":"2020060307285864400_i2168-9709-8-6-256-b37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1399-5618.2008.00461.x","article-title":"The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder","volume":"10","author":"Goldstein","year":"2008","journal-title":"Bipolar Disord"},{"issue":"5","key":"2020060307285864400_i2168-9709-8-6-256-b38","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.4088\/JCP.15m09935","article-title":"Clinical outcomes associated with comorbid posttraumatic stress disorder among patients with bipolar disorder","volume":"77","author":"Passos","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"2020060307285864400_i2168-9709-8-6-256-b39","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.4088\/JCP.16r10897","article-title":"Patients with co-occurring bipolar disorder and posttraumatic stress disorder: a rapid review of the literature","volume":"78","author":"Cerimele","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"2020060307285864400_i2168-9709-8-6-256-b40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4088\/JCP.09m05514yel","article-title":"Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study","volume":"71","author":"Perlis","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2020060307285864400_i2168-9709-8-6-256-b41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S1092852912000119","article-title":"Conceptualizing treatment nonadherence in patients with bipolar disorder and PTSD","volume":"16","author":"Rakofsky","year":"2011","journal-title":"CNS Spectr"},{"issue":"11","key":"2020060307285864400_i2168-9709-8-6-256-b42","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2165\/11310850-000000000-00000","article-title":"Epidemiology and management of anxiety in patients with bipolar disorder","volume":"23","author":"Kauer-Sant'Anna","year":"2009","journal-title":"CNS Drugs"},{"issue":"4","key":"2020060307285864400_i2168-9709-8-6-256-b43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/PRA.0000000000000091","article-title":"Benzodiazepines for PTSD: a systematic review and meta-analysis","volume":"21","author":"Guina","year":"2015","journal-title":"J Psychiatr Pract"}],"container-title":["Mental Health Clinician"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/8\/6\/256\/2096463\/mhc_2018_11_256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/8\/6\/256\/2096463\/mhc_2018_11_256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:57:12Z","timestamp":1775257032000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/8\/6\/article-p256.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.9740\/mhc.2018.11.256","relation":{},"ISSN":["2168-9709"],"issn-type":[{"value":"2168-9709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}